Ceribell CBLL
NASDAQ CBLL
$24.37 -0.63 (-2.52%)
At close: Sep 18, 2026 · 4:00 PM EDT

Ceribell (CBLL) Net Income towards Common Stockholders (2023 - 2026)

Ceribell's (CBLL) quarterly Net Income towards Common Stockholders came in at -$19.3 million in Q2 2026, down 41.23% on a YoY basis from -$32.8 million in Q2 2025, and up 2.38% quarter-over-quarter from -$19.7 million in Q1 2026.

Analysis

Ceribell (CBLL) Net Income towards Common Stockholders (2023 - 2026) Analysis & Trends

Ceribell (CBLL) has reported Net Income towards Common Stockholders for 4 consecutive years, with -$19.3 million the latest figure, recorded in Q2 2026.

  • For the quarter ending Q2 2026, Net Income towards Common Stockholders fell 41.23% year-over-year to -$19.3 million; the trailing twelve-month figure through Jun 2026 stood at -$66.0 million (down 33.56% YoY), and the FY2025 full-year result was -$42.2 million, down 32.24% from the prior year.
  • Net Income towards Common Stockholders grew to -$19.3 million in Q2 2026 per CBLL's latest filing, from -$19.7 million in the prior quarter.
  • Across five years, Net Income towards Common Stockholders topped out at -$7.1 million in Q3 2023 and bottomed at -$19.7 million in Q1 2026.
  • Historically, Net Income towards Common Stockholders has averaged -$12.4 million across 4 years, with a median of -$12.7 million in 2024.
  • The sharpest annual moves came in 2025 and 2026: Net Income towards Common Stockholders dropped 7.56% in 2025, then plunged 54.47% in 2026.
  • Over 4 years, Net Income towards Common Stockholders stood at -$8.3 million in 2023, then tumbled by 51.99% to -$12.6 million in 2024, then dropped by 7.56% to -$13.5 million in 2025, then plunged by 42.44% to -$19.3 million in 2026.
  • According to Business Quant data, Net Income towards Common Stockholders over the past three periods registered -$19.3 million, -$19.7 million, and -$13.5 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Income (Qtr)
1 GE HealthCare Technologies 28.97 Bn 27.09 Bn 2.18 Bn 574.00 Mn
2 Lantheus Holdings 6.56 Bn 5.97 Bn 241.86 Mn 75.03 Mn
3 Heartflow 4.40 Bn 4.03 Bn 53.19 Mn -15.74 Mn
4 Neogen 2.83 Bn 2.64 Bn 107.80 Mn -10.50 Mn
5 Butterfly Network 1.88 Bn 1.75 Bn 23.29 Mn -12.91 Mn
6 Ceribell 931.50 Mn 802.24 Mn 25.94 Mn -19.27 Mn
7 Varex Imaging 779.32 Mn 694.02 Mn 76.70 Mn 15.90 Mn
8 Anbio Biotechnology 755.43 Mn 743.53 Mn - -
9 QuidelOrtho 725.35 Mn 601.95 Mn - -
10 Prenetics Global 339.92 Mn 280.78 Mn 30.20 Mn -8.90 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -19.27 Mn
Mar 31, 2026 -19.74 Mn
Dec 31, 2025 -13.53 Mn
Sep 30, 2025 -13.47 Mn
Jun 30, 2025 -13.64 Mn
Mar 31, 2025 -12.78 Mn
Dec 31, 2024 -12.58 Mn
Sep 30, 2024 -10.42 Mn
Jun 30, 2024 -8.94 Mn
Mar 31, 2024 -8.52 Mn
Dec 31, 2023 -8.27 Mn
Sep 30, 2023 -7.05 Mn